Sunny Pharmtech Inc. (6676) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sunny Pharmtech Inc. (6676:TWSE), powered by AI.

Current Price
$12.95
P/E Ratio
-12.3
Market Cap
1.9B
Sector
Healthcare
What is the Sunny Pharmtech Inc. stock price forecast?

Sunny Pharmtech Inc. is currently trading at $12.95. View real-time AI analysis on Alpha Lenz.

What is Sunny Pharmtech Inc. insider trading activity?

View the latest insider trading data for Sunny Pharmtech Inc. on Alpha Lenz.

What is Sunny Pharmtech Inc.'s P/E ratio?

Sunny Pharmtech Inc.'s P/E ratio is -12.3.

Sunny Pharmtech Inc.

TWSE · 6676
NT$12.95-0.30(-2.26%)
Ask about Sunny Pharmtech Inc.'s future dividend policy...
Alpha Chat Insight

Sunny Pharmtech Inc. trades at a P/E of -12.3 (undervalued) with modest ROE of -13.9%. 3Y revenue CAGR of 20.2% highlights clear growth momentum.

Ask for details

Company Overview

Sunny Pharmtech Inc. is a specialty pharmaceutical company focused on the research, development, manufacturing, and sale of novel and generic drugs. Headquartered in Taoyuan, Taiwan, the company addresses unmet medical needs across Taiwan, the United States, and global markets. Sunny Pharmtech’s core strengths lie in high-value, complex generics and niche therapeutics, particularly within oncology, immunology, and cardiovascular medicine. The company’s product portfolio includes anesthetic ointments, vitamin B12 injections, anti-infective capsules, and treatments for blood disorders, among other advanced therapeutics. Leveraging in-house API development, cutting-edge technologies, and adherence to international quality standards, Sunny Pharmtech offers integrated solutions from drug formulation to commercial manufacturing. Its operations serve both as a pharmaceutical innovator and a contract development and manufacturing organization (CDMO), supporting global partners with process development and regulatory submissions. This positioning underscores the firm's significance in providing innovative, reliable, and accessible healthcare solutions to a diverse, international patient base.

CEODr. Yon-Lian Wu
SectorHealthcare
IndustryBiotechnology
Employees158

Company Statistics

FY 2024

Profile

NT$1.93BMarket Cap
NT$418.01MRevenue
0.00Shares Out
158Employees

Margins

54.16%Gross
-5.72%EBITDA
-38.99%Operating
-37.32%Pre-Tax
-37.32%Net

Valuation

-12.35P/E
1.84P/B
4.61EV/Sales
-90.93EV/EBITDA
-22.25P/FCF

Growth (CAGR)

20.15%Rev 3Yr
12.26%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-9.46%ROA
-13.89%ROE
-8.91%ROIC

Financial Health

NT$138.02MCash & Cash Equivalents
NT$402.65MNet Debt
51.66%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sunny Pharmtech Inc. (ticker: 6676) is a company listed on TWSE in the Healthcare sector (Biotechnology). It has approximately 158 employees. Market cap is $1.9B.

The current price is 12.95 with a P/E ratio of -12.35x and P/B of 1.84x.

ROE is -13.89% and operating margin is -38.99%. Annual revenue is $418M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sunny Pharmtech Inc. (6676) Stock Forecast 2026 $12.95 — Price, Financials & Analyst Targets | Alpha Lenz